Integrated DNA Technologies, NextGen Sciences, GlaxoSmithKline, Stratagene, UK Medical Research Council, Perlegen Life Sciences, Mayo Clinic, Sumitomo | GenomeWeb

Integrated DNA Technologies Will Sell ddRNAi Oligos from Promega

Integrated DNA Technologies has licensed DNA-directed RNA-interference technology from Promega, the company said last week.

Terms of the non-exclusive agreement call for IDT to make and sell oligos for use in ddRNAi. The company, based in Coralville, Iowa, is the first oligonucleotide manufacturer in the US to obtain a ddRNAi license from Promega.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.